Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics
Advanced Materials · 2024
DOI: 10.1002/adma.202405331 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, 2024. Verfasst von Fei Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, the First Affiliated Hospital of Soochow University, Suzhou, 215000, China. Hauptthemen laut MEDLINE: Neoplasms, Microbiota. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 243 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Social Development of Jiangsu Province, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
In recent years, advancements in microbial sequencing technology have sparked an increasing interest in the bacteria residing within solid tumors and its distribution and functions in various tumors. Intratumoral bacteria critically modulate tumor oncogenesis and development through DNA damage induction, chronic inflammation, epigenetic alterations, and metabolic and immune regulation, while also influencing cancer treatment efficacy by affecting drug metabolism. In response to these discoveries, a variety of anti‐cancer therapies targeting these microorganisms have emerged. These approaches encompass oncolytic therapy utilizing tumor‐associated bacteria, the design of biomaterials based on intratumoral bacteria, the use of intratumoral bacterial components for drug delivery systems, and comprehensive strategies aimed at the eradication of tumor‐promoting bacteria. Herein, this review article summarizes the distribution patterns of bacteria in different solid tumors, examines their impact on tumors, and evaluates current therapeutic strategies centered on tumor‐associated bacteria. Furthermore, the challenges and prospects for developing drugs that target these bacterial communities are also explored, promising new directions for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, the First Affiliated Hospital of Soochow University, Suzhou, 215000, China.
- State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RAD-X), Innovation Center of Radiation Medicine of Jiangsu…
- Key Laboratory of Alkene-carbon Fibres-based Technology & Application for Detection of Major Infectious Diseases, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, 215123, China.
ORCID-Profile: Kai Yang
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Social Development of Jiangsu Province
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Gusu Leading Talent Program for Innovation and Entrepreneurship
Zitieren
APA
Peng, F., Hu, M., Su, Z., Hu, L., Guo, L., & Yang, K. (2024). Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics. Advanced Materials. https://doi.org/10.1002/adma.202405331
Vancouver
Peng F, Hu M, Su Z, Hu L, Guo L, Yang K. Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics. Advanced Materials. 2024. doi:10.1002/adma.202405331
BibTeX
@article{Peng2024,
author = {Peng, Fei and Hu, Mengyuan and Su, Zhiyue and Hu, Lin and Guo, Lingchuan and Yang, Kai},
title = {Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202405331}
}
EUVIMED